» Articles » PMID: 19268655

Structural and Functional Characterization of Soluble Endoglin Receptor

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2009 Mar 10
PMID 19268655
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Endoglin, an accessory membrane receptor of transforming growth factor-beta (TGF-beta)1, modulates the cellular response to TGF-beta via its interaction with type I and II TGF-beta receptors. It has been considered a promising target for the development of therapeutics and cancer markers. We have established stable CHO cell lines that efficiently secrete soluble endoglin (s-endoglin) fused with human growth hormone. Two oligomeric forms were observed in a homogeneous preparation of s-endoglin, as a dimer and a tetramer. The dimeric s-endoglin enhanced TGF-beta responsiveness in U937 cells, thus proving its potential for therapeutic applications. Small angle X-ray scattering (SAXS) experiments revealed elongated conformations of both dimeric and tetrameric s-endoglins in solution, suggesting that s-endoglin might undergo conformational adaptations upon TGF-beta binding. The current results provide important references and material for high-resolution structural studies and for medical applications of s-endoglin.

Citing Articles

Association of cord blood Ang-1 and sCD105 levels with bronchopulmonary dysplasia in preterm infants.

Yang J, Wang Y, Wu Y, Fan H, Jin O, Tang L BMC Pediatr. 2024; 24(1):451.

PMID: 39010003 PMC: 11247901. DOI: 10.1186/s12887-024-04932-7.


High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging.

Nejmanova I, Vitverova B, Eissazadeh S, Tripska K, Igreja Sa I, Hyspler R J Cardiovasc Dev Dis. 2021; 8(12).

PMID: 34940528 PMC: 8703792. DOI: 10.3390/jcdd8120173.


Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts.

Vitverova B, Najmanova I, Vicen M, Tripska K, Igreja Sa I, Hyspler R PLoS One. 2020; 15(5):e0233725.

PMID: 32470058 PMC: 7259503. DOI: 10.1371/journal.pone.0233725.


Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma.

Hu J, Guan W, Yan L, Ye Z, Wu L, Xu H Stem Cells Int. 2019; 2019:9060152.

PMID: 31015843 PMC: 6444238. DOI: 10.1155/2019/9060152.


Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy.

Kasprzak A, Adamek A Int J Mol Sci. 2018; 19(12).

PMID: 30563158 PMC: 6321450. DOI: 10.3390/ijms19123887.